EyePoint Pharmaceuticals Inc

NASDAQ:EYPT  
13.35
+0.02 (+0.15%)
6:24:27 PM EDT: $13.20 -0.15 (-1.12%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)921.56M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$3.46 Million
Adjusted EPS-$0.77
See more estimates
10-Day MA$13.02
50-Day MA$11.07
200-Day MA$8.15
See more pivots

EyePoint Pharmaceuticals Inc Stock, NASDAQ:EYPT

480 Pleasant Street, Suite A-210, Watertown, Massachusetts 02472
United States of America
Phone: +1.617.926.5000
Number of Employees: 165

Description

EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.